Skip to main content

Day: September 2, 2021

Fitch Ratings initiate coverage of OSB GROUP PLC

LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the Company) Fitch Ratings initiate coverage of OSB GROUP PLC OSB Group is pleased to announce that Fitch Ratings has published Long-Term Issuer Default Ratings (IDRs) of ‘BBB-‘ with a Stable Outlook for OSB GROUP PLC and OneSavings Bank plc. Andy Golding, Group Chief Executive said, “This is a milestone in the development of OSB Group and this investment grade rating from Fitch confirms the strength of our business and our balance sheet” Enquiries: OSB GROUP PLC Alastair Pate Group Head of Investor Relations   Email: osbrelations@osb.co.uk                                 t: 01634 838 973   Brunswick                                                                             Robin Wrench / Simone Selzer                                 t:  020 7404 5959     Notes to Editors About OSB...

Continue reading

No. 16/2021 – Managers’ transactions

Nasdaq Copenhagen                                                                                Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 2 September 2021 ANNOUNCEMENT no. 16/2021 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 2 September 2021.Name: Joanna Lucyna Iwanowska-NielsenReason for filing: InsiderCompany name: Cemat A/SIdentification code and name: ISIN DK0010271584Transaction type: PurchaseDate: 2 September 2021Market: Nasdaq CopenhagenNumber of traded shares: 40,000Price: 0,915Cemat A/S Jaroslaw Pawel LipinskiCEO This announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no....

Continue reading

AB Science announced today that latest clinical data on long-term survival analyses in ALS will be presented at the 2021 symposium on ALS/MND

PRESS RELEASE AB SCIENCE TO PRESENT LATEST CLINICAL DATA ON LONG-TERM SURVIVAL ANALYSES IN AMYOTROPHIC LATERAL SCLEROSIS AT THE 2021 INTERNATIONAL SYMPOSIUM ON ALS/MND Paris, 2 September, 2021, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that two scientific presentations in amyotrophic lateral sclerosis (ALS) will be shared at the 2021 International Symposium on ALS/MND, which is being held virtually on 7–10 December. This is the largest medical and scientific conference dedicated to advancing science in MND/ALS and is the premier event in the ALS research calendar for discussion on the latest advances in research and clinical management. The accepted abstracts include of one oral presentation during the platform session on Clinical Trials and Trial Design, and one ePoster presentation with accompanying...

Continue reading

No. 15/2021 – Managers’ transactions

Nasdaq Copenhagen                                                                                Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 2 September 2021 ANNOUNCEMENT no. 15/2021 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 1 September 2021.Name: Peter Taero NielsenReason for filing: Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the companyCompany name: Cemat A/SIdentification code and name: ISIN DK0010271584Transaction type: PurchaseDate: 31 August 2021Market: Nasdaq CopenhagenNumber of traded shares: 50,000Price: 0,895Cemat A/S Jaroslaw Pawel LipinskiCEO This announcement has been prepared in a Danish-language and an English-language version. In case...

Continue reading

No. 14/2021 – Managers’ transactions

Nasdaq Copenhagen                                                                                Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 2 September 2021 ANNOUNCEMENT no. 14/2021 Managers’ transactions Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 1 September 2021.Name: Joanna Lucyna Iwanowska-NielsenReason for filing: InsiderCompany name: Cemat A/SIdentification code and name: ISIN DK0010271584Transaction type: PurchaseDate: 31 August 2021Market: Nasdaq CopenhagenNumber of traded shares: 237,314Price: 0,90Cemat A/S Jaroslaw Pawel LipinskiCEO This announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentAnnouncement no. 14...

Continue reading

Klépierre: Klépierre publishes its first-half 2021 financial report

PRESS RELEASE KLÉPIERRE PUBLISHESITS FIRST-HALF 2021 FINANCIAL REPORT Paris – September 2, 2021 Klépierre announced the public release and the filing of its first-half 2021 financial report with the Autorité des marchés financiers (“AMF”) on September 2, 2021. It may be read and downloaded from the Klépierre website, www.klepierre.com, under the “Finance” section.        INVESTOR RELATIONS CONTACTS MEDIA CONTACTSArnaud Courtial, Group Head of IR and Financial Communication+33 (0)1 40 67 57 80 — arnaud.courtial@klepierre.comPaul Logerot, IR Manager +33 (0)1 40 67 53 02 — paul.logerot@klepierre.comJulia Croissant, IR Officer+33 (0)1 40 67 51 68 — julia.croissant@klepierre.com Helene SALMON, Group Head of Corporate& Internal Communications+33 (0)1 40 67 55 16 — helene.salmon@klepierre.com   Wandrille Clermontel, Taddeo+33 (0)6...

Continue reading

Aéroports de Paris SA – Voting rights as of 31 August 2021

September 2nd, 2021 Aéroports de Paris SAInformation regarding the voting rights and shares as of 31 August 2021Statement according to Article L. 233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “Autorité des Marchés Financiers” ISIN: FR0010340141Ticker: ADPListing place: Euronext ParisMarket: Euronext Paris – Compartment A – SRDDate Total number of shares Total number of gross voting rights Total number of net voting rights131/08/2021 98,960,602 171,807,654 171,791,0041 Gross voting rights less shares without voting rights Investor Relations: Audrey Arnoux, Head of Investor Relations +33 6 61 27 07 39 – invest@adp.frPress contact: Lola Bourget, Head of Medias and Reputation Department +33 1 74 25 23 23Groupe ADP develops and manages airports, including Paris-Charles...

Continue reading

COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2021

Paris, 2nd September 2021 – 17:45 COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 August 2021Total Number of Shares Capital Theoretical Number of Voting Rights1 Number of Real Voting Rights2150,179,792 150,179,792 149,005,373    (1) including own shares    (2) excluding own shares      About Coface   COFACE SA is a société anonyme (joint-stock corporation), with a Board of Directors (Conseil d’Administration) incorporated under the laws of France, and is governed by the provisions of the French Commercial Code. The Company is registered with the Nanterre Trade and Companies Register (Registre du Commerce et des Sociétés) under the number 432 413 599. The Company’s registered office is at 1 Place Costes et Bellonte, 92270 Bois Colombes, France.   At the date of...

Continue reading

Tecan launches an accelerated bookbuilding for the placement of new shares to partly refinance the acquisition of Paramit Corporation

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, 2 September 2021 – Tecan Group Ltd. (“Tecan Group” or “Tecan”, SIX Swiss Exchange: TECN) launches an accelerated bookbuilding for the placement of up to 650,000 new registered shares (the “New Shares”) with a par value of CHF 0.10 per share (the “Share Placement”). The net proceeds from the Share Placement will be used to partly refinance the USD 1.0 billion (CHF 920 million) acquisition of Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life science...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.